08/10/2026
EQS-News: Newron Pharmaceuticals S.p.A.
/ Key word(s): Study
Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program
08.10.2026 / 07:00 CET/CEST
The issuer is solely responsible for the content of...
22/09/2026
EQS-News: Newron Pharmaceuticals S.p.A.
/ Key word(s): Half Year Results
Newron presents H1 2026 results and provides corporate update
22.09.2026 / 07:00 CET/CEST
The issuer is solely responsible for the content of this...
08/09/2026
EQS-News: Newron Pharmaceuticals S.p.A.
/ Key word(s): Capital Increase
Newron reports subscription for EUR 5.5 million of shares by investor group as part of up to EUR 38 million total financing to advance Phase 3 evenamide program...
02/09/2026
EQS-News: Newron Pharmaceuticals S.p.A.
/ Key word(s): Study
Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia...
31/08/2026
EQS-News: Sto SE & Co. KGaA
/ Key word(s): Half Year Results
Sto SE & Co. KGaA Group turnover rises by 3.7 % to EUR 805.5 million by the end of June 2026
31.08.2026 / 10:01 CET/CEST
The issuer is solely responsible for...
25/08/2026
EQS Voting Rights Announcement: Adtran Holdings, Inc.
Adtran Holdings, Inc.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
25.08.2026 / 19:00...
04/08/2026
EQS-News: Adtran Holdings, Inc.
/ Key word(s): Quarter Results
ADTRAN Holdings, Inc. reports second quarter 2026 financial results
04.08.2026 / 04:30 CET/CEST
The issuer is solely responsible for the content of this...
31/07/2026
NatWest Markets Plc
/ Key word(s): Half Year Results
NatWest Markets Plc Interim Results 2026
31.07.2026 / 09:40 CET/CEST
NatWest Markets Group
Interim Results 2026
NatWest Markets Plc...
22/07/2026
EQS-Ad-hoc: Adtran Holdings, Inc. / Key word(s): Results / Quarter
Adtran Holdings, Inc.: Preliminary Revenue and Non-GAAP Operating Margin Below Guidance Range and Preliminary Earnings Per Share Expected Below Analyst Consensus for Q2 2026...
22/06/2026
The Middle East conflict continues to have a firm grip on the markets. At the moment, things appear to be easing, and negotiations between the U.S. and Iran are continuing. However, the situation remains fragile.June 22, 2026. FRANKFURT...
07/04/2026
Following last week’s sharp rebound, new threats from Donald Trump regarding the Iran conflict are causing uncertainty on the stock markets this morning. Meanwhile, technical analysts are warning of “long-term signs of a slowdown” for the...
23/03/2026
One of the peculiarities of reality is that it behaves differently than textbooks prescribe. However, this does not mean that textbooks should be discarded; rather, they should be continuously updated. Ali Masarwah, fund analyst and...
06/03/2026
In most cases, federal bonds, which are considered safe, are in demand during a crisis, and yields fall. However, the war with Iran has caused yields to rise. This is because higher inflation is now expected—and, as a result, key interest...
05/03/2026
Will oil and gas prices continue to rise? That is the big question in commodity ETC trading. Turnover is high. Things are not so busy with gold and silver price trackers. March 5, 2026. FRANKFURT (Deutsche Börse). Oil and gas are...
15/09/2025
There are still no signs of a breakout from the sideways trend. It's time to wait and see. On Wednesday, the US Federal Reserve will decide on the key interest rate – and according to firm expectations, it will now fall. 15 September 2025....